Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Xoma initiates phase IIb dose-finding XOMA-052 trial in type 2 diabetes

Feb. 10, 2010

Novel ACC inhibitors in early development at Pfizer

Feb. 10, 2010

Sirtris Pharmaceuticals discovers SIRT activators

Feb. 10, 2010

Merck KGaA claims novel AMP-activated protein kinase activators

Feb. 9, 2010

BioMarin reports preliminary results from phase I/II trial of BMN-110 in MPS IVA

Feb. 8, 2010

7TM Pharma identifies novel CB1 receptor antagonists

Feb. 8, 2010

BioTime reports results of Hextend trial in unstable trauma patients

Feb. 8, 2010

OsteoGeneX claims Wnt pathway modulators for the treatment of bone diseases

Feb. 8, 2010

Prolor reports topline results from phase I study of CTP-modified human growth hormone

Feb. 5, 2010

FDA requests additional information for Protalix's taliglucerase alfa NDA

Feb. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...